LBO — BRYAN MEDICAL CENTER
IRR: 18.5% | MOIC: 2.34x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
18.5%
IRR
2.34x
MOIC
$702.4M
Entry EV
$1.1B
Exit EV
$361.4M
Equity Invested
Sources & Uses
S&UTotal · $702.4M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $272.8M | 38.8% | |
| Sub Debt | $68.2M | 9.7% | |
| Equity | $361.4M | 51.5% | |
| Enterprise Value | $681.9M | 97.1% | |
| Transaction Fees | $20.5M | 2.9% | |
| Total Uses | $702.4M | 100.0% |
Interpretation
INTAt 2.34x MOIC and 18.5% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $108.6M |
| Exit Ev | $1.1B |
| Net Debt At Exit | $294.7M |
| Equity At Exit | $845.9M |
| Equity Invested | $361.4M |
| Total Value Created | $484.5M |
| Value From Growth | $424.6M |
| Value From Multiple | $34.1M |
| Value From Deleveraging | $46.3M |